Cargando…
Physicians and Patients Measure Different Dimension on Assessment for Gatroesophageal Reflux Disease-Related Symptoms
BACKGROUND/AIMS: Gastroesophageal reflux disease is a highly prevalent disease. Assessing treatment efficacy is critical in that clinical endpoints are properly evaluated. Clinical tools for symptoms severity assessment should be discriminative, predictive and evaluative. METHODS: In this study we c...
Autores principales: | Lopez-Alvarenga, Juan Carlos, Sobrino-Cossio, Sergio, Fass, Ronnie, Vargas-Romero, Jose A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228978/ https://www.ncbi.nlm.nih.gov/pubmed/22148107 http://dx.doi.org/10.5056/jnm.2011.17.4.381 |
Ejemplares similares
-
Corrigendum: Physicians and Patients Measure Different Dimension on Assessment for Gatroesophageal Reflux Disease-related Symptoms
por: Lopez-Alvarenga, Juan Carlos, et al.
Publicado: (2012) -
Relief of Night-time Symptoms Associated With Gastroesophageal Reflux Disease Following 4 Weeks of Treatment With Pantoprazole Magnesium: The Mexican Gastroesophageal Reflux Disease Working Group
por: López-Alvarenga, Juan Carlos, et al.
Publicado: (2014) -
Role of altered esophageal intraluminal baseline impedance levels in patients with gatroesophageal reflux disease refractory to proton pump inhibitors
por: Jiang, Liuqin, et al.
Publicado: (2016) -
New and Future Drug Development for Gastroesophageal Reflux Disease
por: Maradey-Romero, Carla, et al.
Publicado: (2014) -
Nonerosive Reflux Disease (NERD) - An Update
por: Hershcovici, Tiberiu, et al.
Publicado: (2010)